Trading Signals: BAX Stock Price Prediction and Forecast (Mon. Dec. 1, 2014 - Wed. Sep. 27, 2023)(Baxter International Inc.)
| BAX latest price $86.4500 (-0.85%) ($86.3700 - $87.5200) on Thu. Dec. 30, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.21% (three month average) | RSI | 76 | Latest Price | $86.4500(-0.85%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | BAX advances 0.3% a day on average for past five trading days. | Weekly Trend | BAX advances 2.8% a week on average for past two weeks. | Market Behavior | Growth stock sell-off for large cap. Normal for small cap. | Correlated ETFs | Broad market will support BAX advance at 0% a week (0% probability) XLV(36%) VYM(35%) SDY(34%) SPLV(34%) XLP(34%) | Factors Impacting BAX price | BAX will decline at least -0.605% in a week (0% probabilities). VIXM(-22%) UUP(-22%) VXX(-1%) TLT(-1%) EDOC(-1%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.605% (StdDev 1.21%) | Hourly BBV | -1 () | Intraday Trend | -1.1% | | | |
|
5 Day Moving Average | $86.51(-0.07%) | 10 Day Moving Average | $85.26(1.4%) | 20 Day Moving Average | $82.97(4.19%) | To recent high | -0.8% | To recent low | 15.9% | Market Cap | $44.105b | | | | Baxter International, Inc. provides portfolio of essential renal and hospital products, including acute and chronic dialysis, sterile IV solutions, infusion systems and devices, parenteral nutrition therapies; premixed and oncolytic injectable, bio surgery products and anesthetics, drug reconstitution systems; and pharmacy automation, software and services. It operates through the following segment: Americas, Europe, Middle East & Africa and Asia-Pacific. The company was founded by Davis Baxter in 1931 and is headquartered in Deerfield, IL. |